(Q43688380)

25 November 2017

title

Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study (English)

1 reference

25 November 2017

1 reference

Pei AY

1

1 reference

25 November 2017

Chan HH

series ordinal

2

1 reference

25 November 2017

Leung TF

series ordinal

3

1 reference

25 November 2017

language of work or name

1 reference

1 June 2001

1 reference

Pediatric Allergy & Immunology

25 November 2017

published in

1 reference

25 November 2017

volume

12

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

154-158

1 reference

Pathogenesis of atopic eczema

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

Immune dysregulation in atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

Immunoglobulin E-binding structures on antigen-presenting cells present in skin and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

Pharmacotherapy of asthma in children, with special reference to leukotriene receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

Asthma therapy with agents preventing leukotriene synthesis or action

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

Use of leukotriene antagonists in childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

The effect of the oral leukotriene antagonist, ICI 204,219, on leukotriene D4 and histamine-induced cutaneous vascular reactions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

7 January 2021

Successful treatment of chronic urticaria with leukotriene antagonists

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

7 January 2021

Antileukotrienes in chronic urticaria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

1 reference

7 January 2021

The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

7 January 2021

Generation of leukotrienes from normal epidermis and their demonstration in cutaneous disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

7 January 2021

Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

7 January 2021

Leukotriene B4 and C4 generation by blood leukocytes after ex vivo stimulation by Ca-ionophore and opsonized zymosan in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3038.2001.012003154.X

7 January 2021

10.1034/J.1399-3038.2001.012003154.X

Identifiers

DOI

1 reference

25 November 2017

1 reference